The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase

Biochemical Pharmacology

Volumn 56, Issue 3, 1998, Pages 307-312

  Graham, Garry G ^a   Kettle, Anthony J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Aurocyanide; Aurothiomalate; Cyanide; Gold; Hypothiocyanite; Inflammation; Rheumatoid arthritis; Thiocyanate

Indexed keywords

AUROTHIOMALATE; HYDROGEN PEROXIDE; MYELOPEROXIDASE; THIOCYANATE;

ARTICLE; CHEMICAL REACTION KINETICS; DRUG ACTIVATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NEUTROPHIL; PRIORITY JOURNAL; REACTION ANALYSIS; RESPIRATORY BURST; SPECTROPHOTOMETRY;

ANTIRHEUMATIC AGENTS; CHLORIDES; CYANIDES; GOLD COMPOUNDS; GOLD SODIUM THIOMALATE; HUMANS; NEUTROPHILS; PEROXIDASE;

EID: 0031659663     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00031-8     Document Type: Article

References (30)

1. Graham GG, Haavisto TM, Jones HM, Champion GD. The effect of cyanide on the uptake of gold by red blood cells. Biochem Pharmacol. 33:1984;1257-1262.
2. 13CNMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate. J Inorg Biochem. 25:1985;163-173.
3. Rudkowski R, Graham GG, Champion GD, Ziegler JB. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes. Biochem Pharmacol. 39:1990;1687-1695.
4. Graham GG, Dale MM. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. II. Evidence for the formation and biological activity of aurocyanide. Biochem Pharmacol. 39:1990;1697-1702.
5. Graham GG, Champion GD, Haddad PR, Joulianos G, Kalambeheti C, Rudkowski R, Ziegler JB. Evidence for the activation of aurothiomalate by its conversion to aurocyanide. Aust NZ J Med. 20:1990;505.
6. Elder RC, Jones WB, Zhao Z, Dorsey JG, Tepperman K. Myochrisine solution structure and reactivity. Metal Based Drugs. 1:1994;363-374.
7. Tepperman K, Zhang Y, Roy R, Floyd R, Zhao Z, Dorsey JG, Elder RC. Transport of the dicyanogold(I) anion. Metal-Based Drugs. 1:1994;433-443.
8. Beswick PH, Slater TF. Modification by metals, sulphydryl reagents and cyanide of the particle stimulated enhancement of oxygen consumption in bovine granulocytes. Chem Biol Interact. 20:1978;373-382.
9. Klebanoff SJ. Everse J, Everse KE, Grisham MB. Peroxidases in chemistry and biology. 1991;1-35 CRC Press, Boca Raton.
10. Stelmaszynska T. Formation of HCN and its chlorination to CICN by stimulated human neutrophils-2. Oxidation of thiocyanate as a source of HCN. Int J Biochem. 18:1986;1107-1114.
11. - system. Biochem Biophys Acta. 567:1979;309-314.
12. Oka S, Sibazaki Y, Tahara S. Direct potentiometric determination of chloride ion in whole blood. Anal Chem. 53:1981;588-593.
13. Wood JL, In: Chemistry and biochemistry of thiocyanic acid and its derivatives (Eds. Newman AA), pp. 156-221. Academic Press, Orlando, Fl, 1975.
14. Van Dalen C, Whitehouse MW, Winterbourn CC, Kettle AJ. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J. 327:1997;487-492.
15. Thomas EL. Pruitt KM, Tenovuo JV. The lactoperoxidase system chemistry and biological significance . 1985;31-53 Marcel Dekker Inc, New York.
16. Hughes MN. Newman AA. Chemistry and biochemistry of thiocyanic acid and its derivatives. 1975;1-67 Academic Press, New York.
17. Kettle AJ, Winterbourn CC. Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J. 252:1988;529-536.
18. Odajima T, Yamazaki I. Myeloperoxidase of the leukocytes of normal blood. I. Reaction of myeloperoxidase with hydrogen peroxide. Biochim Biophys Acta. 206:1970;71-77.
19. Beers RJ, Sizer I. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 195:1952;133-140.
20. Kettle AJ, Winterbourn CC. Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 233:1994;502-512.
21. Kettle AJ, Winterbourn CC. Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode. Biochem J. 263:1989;823-828.
22. -] in the formation of gold metabolites. Metal Based Drugs. 1:1994;351-362.
23. Aune TM, Thomas EL. Accumulation of hypothiocyanite ion during peroxidase-catalysed oxidation of thiocyanate ion. Eur J Biochem. 80:1977;209-214.
24. Pollock JR, Goff HM. Lactoperoxidase-catalyzed oxidation of thiocyanate ion a carbon-13 nuclear magnetic resonance study of the oxidation products . Biochim Biophys Acta. 1159:1992;279-285.
25. Winterbourn CC. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta. 840:1985;204-210.
26. Folkes LK, Candeias LP, Wardman P. Kinetics and mechanisms of hypochlrous acid reactions. Arch Biochem Biophys. 323:1995;120-126.
27. Schuhmann D, Kubicka-Muranyi M, Mirtschewa J, Gunther J, Kind P, Gleichmann E. Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantiantibody formation. J Immunol. 145:1990;2132-2139.
28. Takahashi K, Griem P, Goebel C, Gonzalez J, Gleichmann E. The antirheumatic drug gold, a coin with two faces Au(I) and Au(III). Desired and undesired effects on the immune system . Metal-Based Drugs. 1:1994;483-496.
29. Oxborrow SM, Champion GD, Rudkowski R, Graham GG, Joulianos G, Ziegler JB. The activation of protein bound gold by polymorphonuclear leukocytes. Clin Exp Pharmacol Physiol. (Suppl. 16):1990;207.
30. Elder RC, Zhao Z, Zhang Y, Dorsey JG, Hess EV, Tepperman K. Dicyanogold(I) is a common human metabolite of different gold drugs. J Rheumatol. 20:1993;268-272.